WWM
WST icon

Western Wealth Management’s West Pharmaceutical WST Stock Holding History

Western Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Hold
808
– – 0.01% 839
2026
Q1 		$203K Sell
808
-671
-45% -$167K 0.01% 922
2025
Q4 		$407K Sell
1,479
-15
-1% -$4.1K 0.02% 573
2025
Q3 		$392K Sell
1,494
-84
-5% -$20.4K 0.02% 510
2025
Q2 		$345K Sell
1,578
-20
-1% -$4.28K 0.02% 520
2025
Q1 		$358K Sell
1,598
-5
-0.3% -$1.38K 0.02% 475
2024
Q4 		$525K Hold
1,603
– – 0.03% 444
2024
Q3 		$481K Buy
1,603
+104
+7% +$31.9K 0.03% 479
2024
Q2 		$494K Buy
1,499
+11
+0.7% +$3.89K 0.04% 374
2024
Q1 		$589K Buy
1,488
+100
+7% +$37K 0.05% 328
2023
Q4 		$489K Hold
1,388
– – 0.04% 417
2023
Q3 		$521K Hold
1,388
– – 0.04% 379
2023
Q2 		$531K Hold
1,388
– – 0.05% 361
2023
Q1 		$481K Buy
1,388
+3
+0.2% +$877 0.04% 377
2022
Q4 		$326K Sell
1,385
-1,801
-57% -$427K 0.03% 445
2022
Q3 		$778K Buy
3,186
+54
+2% +$16.5K 0.04% 374
2022
Q2 		$950K Buy
3,132
+146
+5% +$47.5K 0.05% 314
2022
Q1 		$1.23M Buy
2,986
+1,247
+72% +$488K 0.06% 299
2021
Q4 		$813K Buy
+1,739
New +$749K 0.08% 232
2021
Q2 		$613K Buy
1,709
+4
+0.2% +$1.32K 0.06% 315
2021
Q1 		$480K Hold
1,705
– – 0.06% 285
2020
Q4 		$483K Sell
1,705
-27
-2% -$7.58K 0.07% 260
2020
Q3 		$476K Buy
1,732
+10
+0.6% +$2.65K 0.08% 248
2020
Q2 		$391K Sell
1,722
-2
-0.1% -$393 0.07% 266
2020
Q1 		$263K Buy
1,724
+24
+1% +$3.69K 0.06% 292
2019
Q4 		$256K Sell
1,700
-23
-1% -$3.35K 0.04% 343
2019
Q3 		$244K Sell
1,723
-1
-0.1% -$138 0.05% 335
2019
Q2 		$216K Buy
+1,724
New +$203K 0.03% 371

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Western Wealth Management's WST Position: Q2 2026 in Review

Western Wealth Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 808 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #839.

Western Wealth Management first reported a position in WST in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.23M in Q1 2022. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Western Wealth Management held 808 shares of West Pharmaceutical worth $290K as of Q2 2026.
  • Western Wealth Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Western Wealth Management's portfolio in Q2 2026, its #839 holding.
  • Western Wealth Management first reported a position in West Pharmaceutical in Q2 2019 and has held it in 28 quarters since.
  • Western Wealth Management's West Pharmaceutical position peaked at $1.23M in Q1 2022.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.